0001325812-18-000004.txt : 20180108 0001325812-18-000004.hdr.sgml : 20180108 20180108170209 ACCESSION NUMBER: 0001325812-18-000004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180104 FILED AS OF DATE: 20180108 DATE AS OF CHANGE: 20180108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mason Michael CENTRAL INDEX KEY: 0001514291 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36407 FILM NUMBER: 18517046 MAIL ADDRESS: STREET 1: 300 3RD STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALNYLAM PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001178670 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770602661 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 THIRD STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: (617) 551-8200 MAIL ADDRESS: STREET 1: 300 THIRD STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: ALNYLAM PHARMACEUTICALS INC DATE OF NAME CHANGE: 20020724 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2018-01-04 0 0001178670 ALNYLAM PHARMACEUTICALS, INC. ALNY 0001514291 Mason Michael 300 THIRD STREET CAMBRIDGE MA 02142 0 1 0 0 VP, Finance and Treasurer Common Stock 2018-01-04 4 M 0 1388 42.22 A 6352 D Common Stock 2018-01-04 4 M 0 1667 63.0 A 8019 D Common Stock 2018-01-04 4 M 0 3600 88.95 A 11619 D Common Stock 2018-01-04 4 M 0 2750 96.45 A 14369 D Common Stock 2018-01-04 4 M 0 2750 96.45 A 17119 D Common Stock 2018-01-04 4 M 0 10000 97.72 A 27119 D Common Stock 2018-01-04 4 M 0 6187 96.45 A 33306 D Common Stock 2018-01-04 4 M 0 3439 63.0 A 36745 D Common Stock 2018-01-04 4 S 0 5249 130.42 D 31496 D Common Stock 2018-01-04 4 S 0 16500 131.2 D 14996 D Common Stock 2018-01-04 4 S 0 12405 132.18 D 2591 D Common Stock 2018-01-04 4 S 0 1591 132.98 D 1000 D Common Stock 2018-01-04 4 S 0 400 133.83 D 600 D Common Stock 2018-01-04 4 S 0 600 135.0 D 0 D Common Stock 226 I by Managed Account Performance Stock Option 2013 (right to buy) 63.0 2018-01-04 4 M 0 1667 0.0 D 2017-09-20 2023-12-17 Common Stock 1667 0 D Performance Stock Option 2014 (right to buy) 96.45 2018-01-04 4 M 0 2750 0.0 D 2016-02-01 2024-12-17 Common Stock 2750 2750 D Performance Stock Option 2014 (right to buy) 96.45 2018-01-04 4 M 0 2750 0.0 D 2017-07-07 2024-12-17 Common Stock 2750 0 D Stock Option (right to buy) 42.22 2018-01-04 4 M 0 1388 0.0 D 2026-12-20 Common Stock 1388 4162 D Stock Option (right to buy) 63.0 2018-01-04 4 M 0 3439 0.0 D 2023-12-18 Common Stock 3439 0 D Stock Option (right to buy) 88.95 2018-01-04 4 M 0 3600 0.0 D 2025-12-18 Common Stock 3600 3600 D Stock Option (right to buy) 96.45 2018-01-04 4 M 0 6187 0.0 D 2024-12-17 Common Stock 6187 2063 D Stock Option (right to buy) 97.72 2018-01-04 4 M 0 10000 0.0 D 2015-12-07 2025-12-07 Common Stock 10000 0 D All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 2, 2017. Sale prices ranged from $129.74 to $130.72. Sale prices ranged from $130.74 to $131.73. Sale prices ranged from $131.75 to $132.71. Sale prices ranged from $132.75 to $133.71. Sale prices ranged from $133.78 to $134.11. Sale prices ranged from $134.94 to $135.10 The reporting person owns 226 shares of ALNY common stock under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program. The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. /s/ Michael P. Mason 2018-01-08